Nutritional therapy in cancer patients - "In the beginning too little, at the end too much";Ernährungstherapie beim tumorpatienten - "Am anfang zu wenig, am ende zu viel"

Wiener Klinische Wochenschrift

Volumn 117, Issue 19-20, 2005, Pages 663-665

  Weimann, Arved ^a  

^a Klinikum St Georg   (Germany)

Author keywords

Anorexia; Cancer cachexia; Malnutrition

Indexed keywords

ANTHROPOMETRY; CACHEXIA; CANCER PATIENT; COLON CARCINOMA; DIET THERAPY; EDITORIAL; HUMAN; PROTEIN DEGRADATION; WORLD HEALTH ORGANIZATION; ARTICLE;

CACHEXIA; CLINICAL TRIALS; DIET THERAPY; EVIDENCE-BASED MEDICINE; HUMANS; NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS;

EID: 28344443496     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-005-0456-2     Document Type: Editorial

References (25)

1. Pirlich M (2004) Was ist Mangelernährung? Wien Klin Wochenschr 116: 575-578
2. Galvan O, Johannidis M, Widschwendtner A, Bonatti H, Sprinzl GM, Rehak P, Balogh D, Hackl JM (2004) Comparison of different scoring methods for assessing the nutritional status of hospitalised patients. Wien Klin Wochenschr 116: 596-602
3. Kondrup J, Allison SP, Elia M, Vellas B, Plauth M (2003) ESPEN guidelines for nutritional screening. Clin Nutr 22: 415-421
4. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass Jr HO, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Torney DC (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med: 69: 491-497
5. Meyer L, Meyer FR, Dralle H, Lippert H, Gastinger I (2005) East german Study Group for Quality Control in Operative Medicine and Regional Development in Surgery. Langenbecks Arch Surg Aug 6 (Epub ahead of print)
6. Weimann A, Raab R, Selberg O, Bischoff S, Bornemann K, Müller MJ, Meyer HJ (1996) Perioperative changes in body composition and metabolism in patients with colorectal cancer according to tumor stage. Onkologie 19: 424-429
7. Weimann A (2001) Ziele für eine künstliche Ernährung beim Tumorpatienten. Akt Ernähr-Med 26: 167-169
8. Bozzetti F, Bozzetti V (2005) Efficacy of enteral and parenteral nutrition in cancer patients. Nestlé Nutr Workshop Ser Clin Perform Programme 10: 127-142
9. AKE Österreichische Arbeitsgemeinschaft klinische Ernährung (2005) Empfehlungen für die parenterale und enterale Ernä hrungstherapie des Erwachsenen. AKE 2005
10. Arends J, Zürcher G, Fietkau R, Aulbert E, Frick B, Holm E, Kneba M, Mestrom HJ, Zander A (2003) Leitlinien der Deutschen Gesellschaft für Ernährungsmedizin für Enterale Ernährung Onkologie Aktuel Ernaehr Med 28 [Suppl 1]: S61-S68
11. Weimann A, Meyer HJ, Müller MJ, Stenkhoff P, Miholic J, Jähne J, Selberg O, Pichlmayr R (1992) Bedeutung des präoperativen Gewichtsverlustes für die perioperative Stoffwechseladaptation und das Operationsrisiko bei Patienten mit Tumoren im oberen Gastrointestinaltrakt. Langenbecks Arch Chir 377: 45-52
12. Huang Q, Zhang X, Jiang ZW, Lin BZ, Li N, Li JS (2005) Hypoleptinema in gastric cancer patients: relation to body fat mass, insulin and growth hormone. JPEN J Parent Enteral Nutr 29: 229-235
13. Nixon DW, Kutner M, Heymsfield S, Foltz AT, Carty C, Seitz S, Casper K, Evans WK, Jeejeebhoy KN, Daly JM, Poppendiek H, Hoffman FA (1988) Resting energy expenditure in lung and colon cancer. Metabolism 37: 1059-1064
14. Tisdale MJ (2003) Pathogenesis of cancer cachexia. J Support Oncol 1: 159-168
15. Vissers YL, Dejong CH, Luiking YC, Fearon KC, von Meyenfeldt MF, Deutz NE (2005) Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency? Am J Clin Nutr 81: 1142-1146
16. Roth E (2005). L-Arginin: eine Aminosäure mit multiplen Wirkungen. Wien Klin Wochenschr 117: 666-672
17. Busquets S, Figueras MT, Meijsing S, Carbo N, Quinn LS, Almendro V, Argiles JM, Lopez-Soriano FJ (2005) Interleukin-15 decreases proteolysis in skeletal muscle: a direct effect. Int J Mol Med 16: 471-476
18. Selberg O, Weimann A, Meyer HJ, Canzler H, Müller MJ (1991) Lipolyse und Lipidoxidation bei gewichtsstabilen Patienten mit malignen Tumoren des Verdauungstraktes Infusionstherapie 18: 80-84
19. Holm E, Hagmüller E, Staedt U, Schlickeiser G, Günther HJ, Leweling H, Tokus M, Kollmar HB (1995) Substrate balances across colonic carcinomas in humans. Cancer Res 55: 1373-1378
20. Fearon KCH, von Meyenfeldt MF, Moses AGW, van Geenen R, Roy A, Gouma DJ, Giacosa A, Van Gossum A, Bauer J, Barber MD, Aaronson NK, Voss AC, Tisdale MJ (2003) Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomized double blind trial. Gut 52: 1479-1486
21. Barber MD, Fearon KCH, Moses AGW, Murray GD (2005) A double-blind placebo-controlled randomised study of eicosapentaenoic acid diester in patients with cancer cachexia. Clin Nutr 24: 667-668 (Abstr)
22. Breitkreutz R, Tesdal K, Jentschura D, Haas O, Leweling H, Holm (2005) Effects of a high fat diet on body composition in cancer patients receiving chemotherapy. A randomized controlled study. Wien Klin Wochenschr 117: 685-692
23. Kyle UG, Bosaeus I, De Lorenzo AD, Deuerenberg P, Elia M, Manuel Gomez J, Lilienthal Heitmann B, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, MWJ Schols A, Pichard C; ESPEN (2004) Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 23: 1430-1453
24. Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME (2005) Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol 23: 1348-1349
25. Müller MJ (2005) Künstliche Ernährung - Stehen wir wieder am Anfang? Aktuel Ernaehr Med 30: 194-196